Elevated Siglec-1 levels on monocytes, which in clinical practice are considered a marker of disease activity being a surrogate for Type-I interferon (IFN) activity in SLE [31], were associated with higher BMD values in our study. The gene discussed is IFNA1; the disease is systemic lupus erythematosus.